Home

Daniel H. Orenstein

CIK 1494174 · General Counsel · last filed 2023-03-03

Daniel H. Orenstein is a General Counsel who has filed 80 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing shows the insider had shares withheld for taxes covering $31.2K of HCAT on Mar 3, 2023. Across all open-market trades the lifetime net is −$8.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $224.9K across reported positions. 45 SEC filings were submitted jointly with ATHENAHEALTH INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$224.9K

Companies

2

Total Filings

80

Lifetime Open-Market Net

-$8.40M

Filer Profile

Reported Address
311 ARSENAL STREET
WATERTOWN, MA 02472
Related Filers
ATHENAHEALTH INC — 45 joint filings, latest 2015-05-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HCAT General Counsel 133,097 $1.69 $224.9K -$4.78M 37 2023-03-03
ATHENAHEALTH INC (ATHN) Delisted SVP, GC, and Secretary 28,631 $9.59 $274.6K -$3.61M 43 2015-05-13

Recent Filings

80 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-03-03 HCAT Tax (F) −2,186 -$31.2K EDGAR
2023-02-24 HCAT Grant (A) +40,000 $0 EDGAR
2022-12-05 HCAT Tax (F) −4,325 -$46.1K EDGAR
2022-09-08 HCAT Sell (S) −2,838 -$32.0K EDGAR
2022-09-06 HCAT Tax (F) −1,225 -$14.2K EDGAR
2022-06-08 HCAT Sell (S) −2,838 -$42.1K EDGAR
2022-06-03 HCAT Tax (F) −1,224 -$17.5K EDGAR
2022-04-29 HCAT Exer (M) +5,000 $51.7K EDGAR
2022-03-07 HCAT Sell (S) −4,112 -$110.3K EDGAR
2022-03-03 HCAT Mixed +49 -$48.3K EDGAR
Showing 1–10 of 80
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.